Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.
about
Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1/DNA Minor Groove AdductsAccelerated cellular senescence phenotype of GAPDH-depleted human lung carcinoma cellsStructural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activitiesA meta-analysis approach for characterizing pan-cancer mechanisms of drug sensitivity in cell linesA computational strategy to select optimized protein targets for drug development toward the control of cancer diseasesA proteomic analysis of liver after ethanol binge in chronically ethanol treated ratsInsights into role of bromodomain, testis-specific (Brdt) in acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesisHigh-mobility group box 1 and cancer.Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.HMGB1 in health and disease.Usefulness of monitoring γ-H2AX and cell cycle arrest in HepG2 cells for estimating genotoxicity using a high-content analysis system.Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.Genome-wide expression profiling in muscle and subcutaneous fat of lambs in response to the intake of concentrate supplemented with vitamin EDisruption of NAD(+) binding site in glyceraldehyde 3-phosphate dehydrogenase affects its intranuclear interactionsHigh-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistanceGlyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells.The role of high mobility group box 1 (HMGB1) in colorectal cancer.The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma.ERp57/GRP58: a protein with multiple functions.H2AX a promising biomarker for lung cancer: a review.Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeuticsThe combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.Roles of mitochondrial transcription factor A and microRNA-590-3p in the development of bladder cancer.Artificial box C/D RNAs affect pre-mRNA maturation in human cells.Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma.HMGB1 bound to cisplatin-DNA adducts undergoes extensive acetylation and phosphorylation in vivo.The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.Association ofHMGB1andHMGB2genetic polymorphisms with lung cancer chemotherapy response
P2860
Q26778143-BC7FFFD9-EFB0-4451-BBBC-485FE051EEB5Q28243076-FE45A3AE-0690-47A4-8805-246945B34EE7Q28285134-3536D909-3F63-4986-AE70-A36EF1411FC4Q28540936-1A581584-EAB2-491B-9600-F64E0A523F55Q28543105-2775673B-02B1-456F-8954-45F7552282E2Q28568692-C98716B0-028A-4900-AF81-759B65363618Q28571851-4A984502-6673-498A-8DA8-8F6DB7EA2969Q33638306-3883CE27-B9A6-446B-B3D0-422D6D8F44F6Q34518736-B60D7D1D-3FBD-40B7-82C5-D491E2C9141EQ34622835-3351C6C7-7EC9-41CA-81CD-02C960B83C8DQ35198605-0039553A-44CA-4474-B6A4-DEC2AF1A32E7Q35927823-96172071-9B53-489C-8A22-B76D1D2E13D0Q36251675-4911FCFC-C7A6-4FBA-9E50-B766C07C7AC0Q36310442-EC0AAF10-169E-4213-8774-D8B08E466414Q36677697-96CFDB52-F1B1-47D7-9DBB-3A4AC1181EDEQ36952400-EA4CB4BB-A8B5-4464-8DA8-254D5EEB3C70Q37109252-293A2828-40CC-4B81-A4BA-10C8DC747EDCQ37397248-87F3CD1A-367F-4330-A9C4-665315504041Q37620415-30264485-A253-4B4B-820D-E4AD0A11AB91Q37685447-EE1952FC-A2D5-4476-A7EF-945A13ADD76AQ37689423-482AAB1D-1617-4D90-A5E7-E476C424F415Q37916360-8614DCD5-5489-40C2-B473-E431AAECF3B8Q38155902-38FD1667-3082-44FD-AD41-A7097792CD6BQ38507628-9A2C07EB-94E4-4289-8453-D1EA8570936BQ38673953-9C7C46BA-E784-4834-86EE-6AC228B7F7E0Q38971959-159B86BC-91BE-47C6-9B32-EA3DD6A89521Q39445097-CF661C23-1369-4A2D-9640-0C91C92964C8Q42959491-A24DD7A8-167B-4A56-83CE-0C3AE7197D18Q43195973-14F6E259-2087-492A-A9C0-EDDA1EC8BAF4Q43244789-B5A89F71-66A1-427F-9760-0C1D4F95A43DQ49822836-CB632ECD-41A0-4684-B691-F454D7DAE384Q55181875-564F008A-F04B-4054-A63F-9FA213125971Q57500224-45307257-8948-4F06-B103-54280D16CD16
P2860
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chromatin-associated proteins ...... emotherapy-induced DNA damage.
@en
Chromatin-associated proteins ...... emotherapy-induced DNA damage.
@nl
type
label
Chromatin-associated proteins ...... emotherapy-induced DNA damage.
@en
Chromatin-associated proteins ...... emotherapy-induced DNA damage.
@nl
prefLabel
Chromatin-associated proteins ...... emotherapy-induced DNA damage.
@en
Chromatin-associated proteins ...... emotherapy-induced DNA damage.
@nl
P2093
P2860
P1476
Chromatin-associated proteins ...... emotherapy-induced DNA damage.
@en
P2093
Evgeny Y Krynetskiy
Manali S Phadke
Natalia F Krynetskaia
Sachin H Jadhav
P2860
P304
P356
10.1158/1535-7163.MCT-08-0695
P577
2009-04-01T00:00:00Z